MARKET

SLP

SLP

Simulations Plus Inc
NASDAQ
41.15
-0.20
-0.48%
After Hours: 41.15 0 0.00% 16:00 03/28 EDT
OPEN
41.35
PREV CLOSE
41.35
HIGH
41.91
LOW
41.02
VOLUME
69.06K
TURNOVER
0
52 WEEK HIGH
52.69
52 WEEK LOW
32.64
MARKET CAP
821.65M
P/E (TTM)
78.77
1D
5D
1M
3M
1Y
5Y
Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)
TipRanks · 16h ago
Weekly Report: what happened at SLP last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at SLP last week (0311-0315)?
Weekly Report · 03/18 09:21
Adobe Systems (ADBE) Tops Q1 Earnings and Revenue Estimates
NASDAQ · 03/14 21:15
Weekly Report: what happened at SLP last week (0304-0308)?
Weekly Report · 03/11 09:21
Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Health Catalyst reported strong Q4 results, showing growth in technology and professional services revenue. The company's growth initiatives, such as its TEMS offering and next-gen data platform, are expected to drive growth and margin expansion. HCAT's long-term guidance of exceeding $100 million in EBITDA by FY28 is achievable. I recommend a buy rating for Health Catalyst.
Seeking Alpha · 03/09 09:50
Simulations Plus And University Of Bath Awarded FDA Grant
Benzinga · 03/05 13:31
Weekly Report: what happened at SLP last week (0226-0301)?
Weekly Report · 03/04 09:21
More
About SLP
Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. The Company's segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. The Company provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. Its software and consulting services are provided to various industries, including biotechnology and cosmetics.

Webull offers Simulations Plus Inc stock information, including NASDAQ: SLP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLP stock methods without spending real money on the virtual paper trading platform.